NMRA FY 2021 Earnings — Neumora Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

NMRANeumora Therapeutics, Inc. Common Stock

$586M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$237M

Net Income

-$237M

EPS (Diluted)

$-1.56

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$76M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$429M

Total Liabilities

$755M

Stockholders' Equity

-$325M

Cash & Equivalents

$409M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$237M	-$96M	-148.5%
Net Income	-$237M	-$99M	-139.1%